📰 David Joyner News
Page 7 - David Joyner News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Joyner. Real-time updates on events, politics, business and more.
June 3, 2023
Here, FEMAIL reveals the very mixed fortunes of some of the top childrens TV presenters, including the stars of Balamory, Barney and Cbeebies.
May 23, 2023
While the top three PBMs’ aggregate share of claims was similar to the figures from 2021, the study indicated that Cigna’s share declined due to customer losses while OptumRx’s share grew slightly.
May 16, 2023
This Week in Washington: Debt Ceiling Continues to Loom Over the Capitol; DEA Extends COVID-19 Controlled Medications Prescribing Telehealth Flexibilities...
May 15, 2023
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and...
May 12, 2023
Members of the U.S. Senate Committee on Health, Education, Labor and Pensions conducted a hearing on May 10 to investigate insulin affordability and what caused prices to increase during the past decade. Executives from the three leading insulin manufacturers and the three leading pharmacy benefit managers (PBMs) in the U.S. provided testimony and answered a wide range of questions from
May 12, 2023
WASHINGTON — U.S. senators sparred with pharmaceutical companies and pharmacy benefit managers during a Wednesday hearing on the costs of insulin and other prescription medications. Louisiana Sen. …
May 11, 2023
An Eli Lilly & Co. logo is featured on a box of insulin medications in this arranged photo of a pharmacy in Princeton, Illinois.
May 11, 2023
This 'is a moral issue,' Sen. Bernie Sanders said during the hearing
May 10, 2023
The hearing was held less than two months after Sanofi, Novo Nordisk and Eli Lilly announced that they would cap the cost of insulin and drugs used by patients with diabetes.
May 9, 2023
This Week in Washington: Debt Limit fight continues; Disagreements arise during Senate HELP Committee mark-up of PBM and Generic Drug Competition Bills...